HARSHAWARDHAN RAO

Mr. HARSHAWARDHAN RAO

Department of Pharmacy, Saraswati Institute of Pharmaceutical Education & Research, Mohali, India
orcid
Open For Collaborations

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

14 February 2025 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
PVPeetha Vanaja
Peetha Vanaja
NMN. S. Hari Narayana Moorthy
N. S. Hari Narayana Moorthy
VRVivek Singh Rajpoot
Vivek Singh Rajpoot
HARSHAWARDHAN RAOHARSHAWARDHAN RAO
HARSHAWARDHAN RAO
RGRohit Kumar Goswami
Rohit Kumar Goswami
KRKareti Srinivasa Rao
Kareti Srinivasa Rao
Purpose: To explore the phytochemical composition of Schleichera oleosa bark and evaluate its potential antimalarial activity through in vitro and in silico analyses.Methods: The bark of S. oleosa was subjected to Soxhlet extraction using petroleum ether, chloroform, and methanol. The quantitative analysis of the extracts was performed to determine total phenolic, flavonoid, and tannin contents. Advanced analytical techniques such as Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were employed to identify 175 phytoconstituents from the methanolic extract In-vitro antimalarial activity was assessed against Plasmodium falciparum using the candle jar method, measuring parasite growth inhibition. The inhibitory concentration (IC50) values were calculated and compared with standard antimalarial drugs, chloroquine and quinine. Furthermore, computational analyses, including molecular docking and molecular dynamics simulations, were conducted to evaluate the interactions of identified phytochemicals with key malarial targets (1CEQ and 4ZL4). The efficacy of these compounds was compared with standard drugs like artesunate and chloroquine. Additionally, ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiling and drug-likeness assessments were performed.Results: The methanolic extract of S. oleosa exhibited promising in-vitro antimalarial activity with an average IC50 value of 0.780 μg/mL, which, while higher than chloroquine (0.020 μg/mL) and quinine (0.268 μg/mL), still demonstrated significant efficacy. GC-MS and LC-MS analyses identified 175 phytoconstituents, among which two novel lead compounds, scillarenin and 4-[(Z)-(6-hydroxy-3-oxo-1-benzofuran-2(3H)-ylidene) methyl] phenyl beta-Dglucopyranoside, exhibited the highest docking scores and favorable ADMET profiles. Molecular docking and dynamics simulations confirmed strong binding affinities to malarial targets, surpassing some standard drugs in efficacy.Conclusion: This study reports, for the first time, the antimalarial potential of bioactive constituents derived from the bark of S. oleosa. The identified compounds, scillarenin and 4-[(Z)-(6-hydroxy-3-oxo-1-benzofuran-2(3H)-ylidene) methyl] phenyl beta-D-glucopyranoside, demonstrated promising antiplasmodial activity, validating traditional medicinal claims. The findings highlight the potential of S. oleosa as a source of novel antimalarial agents with fewer side effects compared to existing therapies. Further in vivo studies are warranted to confirm these results and support the development of new antimalarial drugs. This groundbreaking discovery contributes to the growing evidence supporting the role of medicinal plants in drug discovery.

14 August 2026 in In Silico Research in Biomedicine
Verified
Journal Article
Open access
ASAditya Soni
Aditya Soni
AKAniket Kumar
Aniket Kumar
HARSHAWARDHAN RAOHARSHAWARDHAN RAO
HARSHAWARDHAN RAO
MSMadan Singh
Madan Singh
VRVivek Singh Rajpoot
Vivek Singh Rajpoot
NMN.S. Hari Narayana Moorthy
N.S. Hari Narayana Moorthy

28 July 2026 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MSManeesh Shakya
Maneesh Shakya
SPSanjeev Kumar Patel
Sanjeev Kumar Patel
MSMadan Singh
Madan Singh
HARSHAWARDHAN RAOHARSHAWARDHAN RAO
HARSHAWARDHAN RAO
NMNs Hari Narayana Moorthy
Ns Hari Narayana Moorthy
ATAkhilesh Tiwari
Akhilesh Tiwari
Neuroinflammation is a major complex reaction that causes Neurodegenerative Diseases (ND) and cognitive behavioural disorders such as Alzheimer's Disease (AD), Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neuroinflammation can be regulated by different types of enzymes and proteins, including acetyl- and butyrylcholinesterases, cyclooxygenases, kinases, and the accumulation of Amyloid-beta (Aβ) plaques and hyperphosphorylated tau protein. Due to the complex physiology of enzymes and proteins, ND cannot be cured permanently yet. Therefore, we need to design and synthesise novel small molecules with high selectivity and inhibitory properties against enzymes and proteins associated with neuroinflammation. In recent decades, researchers have examined a range of different heterocyclic scaffolds for their ability to fight neuroinflammation. The 1,2,4-triazole scaffold, especially its 5-thiol and 3-thione derivatives, is a chemically flexible heterocyclic scaffold that has attracted significant attention due to its wide range of biological activities and promising drug-like properties. As a review methodology, comprehensive literature searches of the PubMed, Scopus, Web of Science (WoS), ScienceDirect, and DOAJ databases were conducted using keywords to gather information on synthesis, in vitro (IC50 values), in vivo biology, and in silico approaches related to the 1,2,4-triazole-targeted scaffold. This literature review highlights 1,2,4-triazole scaffold 5-thiol and 3-thione derivatives, potent compounds from the synthesised derivatives, presenting synthetic schemes, biological activity data, and in silico studies. Molecular docking, in silico predictions, and preclinical experiments are summarised in detail to show how they can be used in medicinal drug discovery. The goal of this review is to provide a source of information that will help with future efforts to design new neuroprotective agents based on the 1,2,4-triazole scaffold